SCOPUS 정보 검색 플랫폼

Drugs in R and D

Volumn 4, Issue 5, 2003, Pages 323-325

Ketoconazole foam - Connetics. Connetics ketoconazole foam

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CYTOCHROME P450; DRUG CARRIER; ERGOSTEROL; EXTINA; FUNGAL ENZYME; KETOCONAZOLE; PLACEBO;

ARTICLE; BURNING SENSATION; CANDIDA; CELL WALL; CLINICAL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; CREAM; DRUG ABSORPTION; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG PENETRATION; DRUG RESEARCH; FOAM; HUMAN; INTRADERMAL DRUG ADMINISTRATION; LIPOGENESIS; MYCOSIS; NONHUMAN; OINTMENT; PILOT STUDY; PRIORITY JOURNAL; PUBLICATION; REGISTRATION; SEBORRHEIC DERMATITIS; SKIN DISEASE; SKIN MANIFESTATION; SKIN PENETRATION; UNITED STATES;

EID: 0141615678 PISSN: 11745886 EISSN: None Source Type: Journal
DOI: 10.2165/00126839-200304050-00009 Document Type: Article

Times cited : (2)

References (5)

1
- 85009054608
- Connetics Corporation. Connetics Presents Scientific Posters at American Academy of Dermatology's 61st Annual Meeting. Media Release: 20 Mar Available from URL
- Connetics Corporation. Connetics Presents Scientific Posters at American Academy of Dermatology's 61st Annual Meeting. Media Release: 20 Mar 2003. Available from URL: http://www.connetics.com
- (2003)

2
- 85009046834
- A randomized, open-label study to evaluate the comparative bioavailability of ketoconazole foam, 2%, versus ketoconazole 2% cream in the treatment of moderate to severe seborrheic dermatitis
- 21 Mar
- Koller T, Rocco-Wood S, Yaroshinsky A, et al. A randomized, open-label study to evaluate the comparative bioavailability of ketoconazole foam, 2%, versus ketoconazole 2% cream in the treatment of moderate to severe seborrheic dermatitis. 61st Annual Meeting of the American Academy of Dermatology : 159, 21 Mar 2003
- (2003) 61st Annual Meeting of the American Academy of Dermatology , pp. 159
- Koller, T.¹ Rocco-Wood, S.² Yaroshinsky, A.³

3
- 0141525646
- Impact of formulation on ketoconazole skin penetration and drug distribution in vitro
- 21 Mar
- Huang X, Tanojo H, Lenn J. Impact of formulation on ketoconazole skin penetration and drug distribution in vitro. 61st Annual Meeting of the American Academy of Dermatology : 113, 21 Mar 2003
- (2003) 61st Annual Meeting of the American Academy of Dermatology , pp. 113
- Huang, X.¹ Tanojo, H.² Lenn, J.³

4
- 85009049009
- Enhanced ketoconazole bioavailability from a foam formulation: Contribution of biological and nonbiological components
- 21 Mar
- Huang X, Tanojo H, Lenn J, et al. Enhanced ketoconazole bioavailability from a foam formulation: contribution of biological and nonbiological components. 61st Annual Meeting ofthe American Academy of Dermatology : 113, 21 Mar 2003
- (2003) 61st Annual Meeting Of the American Academy of Dermatology , pp. 113
- Huang, X.¹ Tanojo, H.² Lenn, J.³

5
- 85009055348
- Connetics Announces Positive Extina Phase III Trial Results
- Connetics Corporation. Media Release: 23 Apr Available from URL
- Connetics Corporation. Connetics Announces Positive Extina Phase III Trial Results. Media Release: 23 Apr 2003. Available from URL http://www.connetics.com
- (2003)

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.